We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

110 hedge funds and large institutions have $352M invested in Dynavax Technologies in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more call options, than puts

Call options by funds: $628K | Put options by funds: $355K

9% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 34

6% less funds holding

Funds holding: 117110 (-7)

9% less capital invested

Capital invested by funds: $388M → $352M (-$36.2M)

32% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 22

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
110
Holders Change
-7
Holders Change %
-5.98%
% of All Funds
3.18%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
15
Increased
31
Reduced
34
Closed
22
Calls
$628K
Puts
$355K
Net Calls
+$273K
Net Calls Change
+$400K
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$62.5M -$991K -53,431 -2%
RCM
2
RA Capital Management
Massachusetts
$32.3M
Westfield Capital Management
3
Westfield Capital Management
Massachusetts
$24.7M +$3.99M +215,268 +19%
State Street
4
State Street
Massachusetts
$24.7M +$9.04M +487,430 +55%
PC
5
Polar Capital
United Kingdom
$19.4M +$6.51M +350,996 +48%
Vanguard Group
6
Vanguard Group
Pennsylvania
$16.4M +$2.58M +139,337 +18%
BIT
7
BlackRock Institutional Trust
California
$14.5M +$1.17M +63,346 +9%
Franklin Resources
8
Franklin Resources
California
$14.2M +$7.58M +408,660 +108%
BC
9
Broadfin Capital
New York
$13.8M +$761K +41,010 +6%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$13.3M +$11.9M +644,114 +672%
BCPEM
11
Bain Capital Public Equity Management
Massachusetts
$12.9M -$1.58M -84,996 -11%
BFA
12
BlackRock Fund Advisors
California
$12M +$364K +19,627 +3%
PI
13
Putnam Investments
Massachusetts
$10.4M +$10.7M +578,024 New
HM
14
HealthCor Management
New York
$8.67M -$28.2M -1,520,502 -76%
Northern Trust
15
Northern Trust
Illinois
$6.07M -$125K -6,744 -2%
AC
16
Amici Capital
New York
$5.19M -$7.88M -425,000 -60%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$4.11M -$747K -40,254 -15%
Ameriprise
18
Ameriprise
Minnesota
$3.82M +$614K +33,114 +18%
OAM
19
Oxford Asset Management
United Kingdom
$3.59M +$3.7M +199,316 New
KCM
20
Kingdon Capital Management
New York
$3.5M -$3.47M -187,061 -49%
PAM
21
Panagora Asset Management
Massachusetts
$3.28M -$7.29K -393 -0.2%
Millennium Management
22
Millennium Management
New York
$2.79M -$8.73K -471 -0.3%
BA
23
BlackRock Advisors
Delaware
$2.72M +$1.93M +104,092 +223%
William Blair & Company
24
William Blair & Company
Illinois
$2.71M +$218K +11,760 +8%
Morgan Stanley
25
Morgan Stanley
New York
$2.63M -$54.3K -2,929 -2%

DVAX Hedge Fund Activity: Q1 2014 in Review

110 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q1 2014, worth a combined $352M — down 9.3% from $388M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of DVAX and 15 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 31 added.

The largest buyer was Fidelity Investments, adding an estimated $11.9M. The largest seller was HealthCor Management, cutting an estimated $28.2M.

  • 110 institutional investors held Dynavax Technologies (DVAX) as of Q1 2014, down from 117 in Q4 2013.
  • Funds reported $352M of Dynavax Technologies stock for Q1 2014, down 9.3% quarter-over-quarter.
  • 15 funds opened new Dynavax Technologies positions in Q1 2014 and 22 closed out, a net change of -7 holders.
  • The largest Dynavax Technologies buyer in Q1 2014 was Fidelity Investments, an estimated $11.9M added.
  • The largest Dynavax Technologies seller in Q1 2014 was HealthCor Management, an estimated $28.2M sold.

Based on aggregated 13F filings for Q1 2014.